- NCI’s Report to the Nation: Cancer Rates Continue to Decline, Liver Cancer the Exception
- A New Gene Variant May Explain Cancer-Related Outcomes in African-Americans
- ASH's 5 New Choosing Wisely Recommendations for Hematologists
- Advances in Multiple Myeloma Generate Excitement at ASH 2015
- First Precision Medicine Trial in Cancer Prevention Identifies Patients for Chemoprevention
- Medicare Will Now Reimburse Physicians for End-of-Life Discussions with Patients
- New Scoring System Can Improve Lung Cancer Diagnosis
- First Consensus Statement on High-Quality Palliative Care Issued by ASCO/AAHPM
- Medicare to Cover More of the Cost of Blincyto, Citing Substantial Benefits
- FDA Grants Priority Review for 2 Investigational Cancer Drugs
- Current System Favors Development of Drugs for Late-Stage Cancer
- Top US Oncologists Issue a Call to Lower Costs of Cancer Drugs, Assess Value
- Inovio Launches Immunotherapy Trial in Prostate Cancer
- European Regulatory Agency Grants Accelerated Review for 2 Multiple Myeloma Drugs
- Partnership between Genomics and Big Data Companies Promotes Next-Generation Sequencing Innovation
- Eli Lilly and Immunocore Launch New Collaboration to Develop Next-Generation Immuno-oncology Therapies
- Biosimilars Focus on Oncology, Could Reach $55 Billion by 2020
- ImmunoCellular Therapeutics and Novella Clinical to Collaborate on a Phase 3 Trial in Glioblastoma
- House Passes New Medicare Bill That Includes a Value-Based Insurance Design Pilot Project
Results 1 - 6 of 6